BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12084007)

  • 1. Neutrophil elastase inhibitors as treatment for COPD.
    Ohbayashi H
    Expert Opin Investig Drugs; 2002 Jul; 11(7):965-80. PubMed ID: 12084007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease).
    Roghanian A; Sallenave JM
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):125-44. PubMed ID: 18518838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase.
    Lucas SD; Costa E; Guedes RC; Moreira R
    Med Res Rev; 2013 Jun; 33 Suppl 1():E73-101. PubMed ID: 21681767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of equine neutrophil elastase release and superoxide anion generation following secretagogue activation: a potential mechanism for antiproteinase inactivation.
    Dagleish MP; Pemberton AD; Brazil TJ; McAleese SM; Miller HR; Scudamore CL
    Vet Immunol Immunopathol; 1999 Dec; 72(3-4):257-75. PubMed ID: 10628671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteases involved in airway inflammation of COPD].
    Kasagi S; Seyama K; Fukuchi Y
    Nihon Rinsho; 2003 Dec; 61(12):2113-8. PubMed ID: 14674319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase.
    Leahy D; Grant C; Jackson A; Duff A; Tardiota N; Van Haeften J; Chen X; Peake JM; Kruppa MD; Smith ET; Johnson DA; Lott WB; Harris JM
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.
    Kelly-Robinson GA; Reihill JA; Lundy FT; McGarvey LP; Lockhart JC; Litherland GJ; Thornbury KD; Martin SL
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
    Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
    Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical model of protease-antiprotease homeostasis failure in chronic obstructive pulmonary disease (COPD).
    Cox LA
    Risk Anal; 2009 Apr; 29(4):576-86. PubMed ID: 19000077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory activity of neutrophil elastase inhibitors.
    Tremblay GM; Janelle MF; Bourbonnais Y
    Curr Opin Investig Drugs; 2003 May; 4(5):556-65. PubMed ID: 12833649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for chronic obstructive pulmonary disease in the 21st century.
    Donnelly LE; Rogers DF
    Drugs; 2003; 63(19):1973-98. PubMed ID: 12962514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils and protease/antiprotease imbalance.
    Stockley RA
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S49-52. PubMed ID: 10556170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neutrophil in chronic obstructive pulmonary disease.
    Hoenderdos K; Condliffe A
    Am J Respir Cell Mol Biol; 2013 May; 48(5):531-9. PubMed ID: 23328639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel neutrophil elastase inhibitors as a treatment for neutrophil-predominant inflammatory lung diseases.
    Ohbayashi H
    IDrugs; 2002 Sep; 5(9):910-23. PubMed ID: 12800053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
    Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B
    J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel benzoxazinone derivative as potent human neutrophil elastase inhibitor: Potential implications in lung injury.
    Sengupta S; Reddy JR; Rajesh N; Jaiswal A; Mabalirajan U; Palakodety RK; Mukherjee P; Bandyopadhyay A
    Eur J Pharmacol; 2022 Sep; 931():175187. PubMed ID: 35952844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To live and die in the LA (lung airway): mode of neutrophil death and progression of chronic obstructive pulmonary disease.
    Minematsu N; Shapiro SD
    Am J Respir Cell Mol Biol; 2007 Aug; 37(2):129-30. PubMed ID: 17634347
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury.
    Bless NM; Smith D; Charlton J; Czermak BJ; Schmal H; Friedl HP; Ward PA
    Curr Biol; 1997 Nov; 7(11):877-80. PubMed ID: 9382799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease.
    Lodge KM; Vassallo A; Liu B; Long M; Tong Z; Newby PR; Agha-Jaffar D; Paschalaki K; Green CE; Belchamber KBR; Ridger VC; Stockley RA; Sapey E; Summers C; Cowburn AS; Chilvers ER; Li W; Condliffe AM
    Am J Respir Crit Care Med; 2022 Apr; 205(8):903-916. PubMed ID: 35044899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.